Table 2.
Intermediate uveitis, posterior uveitis, and panuveitis distribution in key US studies*
| Present study (n=491) | Gritz and Wong15 (n=310)** | Oruc et al8 (n=853) | Rodriguez et al16 (n=1,237) | Merrill et al7 (n=385) | Henderly et al17 (n=600) | |
|---|---|---|---|---|---|---|
| Anterior uveitis | 67.60% | 86.50% | 22.27% | 51.50% | 25.00% | 27.80% |
| Intermediate uveitis | 5.30% | 3.60% | 11.02% | 13.10% | 12.00% | 15.40% |
| Posterior uveitis | 12.60% | 2.60% | 48.53% | 19.40% | 24.00% | 38.40% |
| Panuveitis | 14.50% | 6.10% | 18.17% | 16.00% | 38.00% | 18.40% |
Notes:
*
Anterior uveitis percentages included here for reference.
**
Numbers reflect data with indeterminate location cases removed.